Cargando…
Expansion of Knowledge on OCT1 Variant Activity In Vitro and In Vivo Using Oct1/2(−/−) Mice
The role of organic cation transporter 1 (OCT1) in humans is gaining attention as data emerges regarding its role in physiology, drug exposure, and drug response. OCT1 variants with decreased in vitro function correlate well with altered exposure of multiple OCT1 substrates in variant carriers. In t...
Autores principales: | Morse, Bridget L., Chen, Lisa Hong, Catlow, John T., Fallon, John K., Smith, Philip C., Hillgren, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917185/ https://www.ncbi.nlm.nih.gov/pubmed/33658943 http://dx.doi.org/10.3389/fphar.2021.631793 |
Ejemplares similares
-
OCT1 Polyspecificity—Friend or Foe?
por: Meyer, Marleen J., et al.
Publicado: (2021) -
Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1
por: Uddin, Muhammad Erfan, et al.
Publicado: (2021) -
Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015) -
Isobutyrylcarnitine as a Biomarker of OCT1 Activity and Interspecies Differences in its Membrane Transport
por: Jensen, Ole, et al.
Publicado: (2021) -
Molecular basis of polyspecific drug binding and transport by OCT1 and OCT2
por: Suo, Yang, et al.
Publicado: (2023)